Novel Uses for Oral Solid Doses Driving Lifecycle Management Strategies

Whitepaper

With few potential blockbuster drugs in the pharma pipeline right now, drug companies are increasingly looking at other options to meet the needs of patients and increase revenue in the oral solid dosage (OSD) arena. Current areas of exploration include novel drug combinations, oral delivery of large molecules that were available only as injectables, and perhaps most interesting, drugs that carry digital, ingestible sensors that can send information directly to a physician.

Author: Anil Kane, PhD, Global Head of Technical and Scientific Affairs at Patheon, by Thermo Fisher Scientific

Download whitepaper

Ready to discuss your project?

Connect with us